Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0W9RM
|
||||
| Former ID |
DNC014731
|
||||
| Drug Name |
4-Methyl-3-(2-oxo-azetidin-1-yl)-benzoic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H11NO3
|
||||
| Canonical SMILES |
CC1=C(C=C(C=C1)C(=O)O)N2CCC2=O
|
||||
| InChI |
1S/C11H11NO3/c1-7-2-3-8(11(14)15)6-9(7)12-5-4-10(12)13/h2-3,6H,4-5H2,1H3,(H,14,15)
|
||||
| InChIKey |
XLQAIEGAEHIXRJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-lactamase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 1988 Feb;31(2):370-4.N-aryl 3-halogenated azetidin-2-ones and benzocarbacephems, inhibitors of beta-lactamases. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.